79 related articles for article (PubMed ID: 20032452)
1. Correlation between WT1 expression and cell proliferation in endometrial cancer.
Dohi S; Ohno S; Ohno Y; Soma G; Kyo S; Inoue M
Anticancer Res; 2009 Nov; 29(11):4887-91. PubMed ID: 20032452
[TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical detection of WT1 protein in endometrial cancer.
Ohno S; Dohi S; Ohno Y; Kyo S; Sugiyama H; Suzuki N; Inoue M
Anticancer Res; 2009 May; 29(5):1691-5. PubMed ID: 19443388
[TBL] [Abstract][Full Text] [Related]
3. WT1 expression correlates with angiogenesis in endometrial cancer tissue.
Dohi S; Ohno S; Ohno Y; Kyo S; Soma G; Sugiyama H; Inoue M
Anticancer Res; 2010 Aug; 30(8):3187-92. PubMed ID: 20871039
[TBL] [Abstract][Full Text] [Related]
4. Wilms Tumor Gene (WT1) and p53 expression in endometrial carcinomas: a study of 130 cases using a tissue microarray.
Dupont J; Wang X; Marshall DS; Leitao M; Hedvat CV; Hummer A; Thaler H; O'Reilly RJ; Soslow RA
Gynecol Oncol; 2004 Aug; 94(2):449-55. PubMed ID: 15297187
[TBL] [Abstract][Full Text] [Related]
5. Proliferating cell nuclear antigen in endometrial carcinoma: pretreatment identification of high-risk patients.
Garzetti GG; Ciavattini A; Goteri G; De Nictolis M; Romanini C
Gynecol Oncol; 1996 Apr; 61(1):16-21. PubMed ID: 8626110
[TBL] [Abstract][Full Text] [Related]
6. The significance of Wilms Tumor Gene (WT1) and p53 expression in curettage specimens of patients with endometrial carcinomas.
Matalka I; Obeidat B; Mohtaseb A; Awamleh A
Pathol Res Pract; 2013 Jan; 209(1):19-23. PubMed ID: 23207289
[TBL] [Abstract][Full Text] [Related]
7. Wilms' tumor gene 1 (WT1) in endometrial carcinoma.
Coosemans A; Moerman P; Verbist G; Maes W; Neven P; Vergote I; Van Gool SW; Amant F
Gynecol Oncol; 2008 Dec; 111(3):502-8. PubMed ID: 18929401
[TBL] [Abstract][Full Text] [Related]
8. Natural killer cell activity in stage I endometrial carcinoma: correlation with nuclear grading, myometrial invasion, and immunoreactivity of proliferating cell nuclear antigen.
Garzetti GG; Ciavattini A; Goteri G; Tranquilli AL; Muzzioli M; Fabris N; De Nictolis M; Romanini C
Gynecol Oncol; 1994 Oct; 55(1):111-4. PubMed ID: 7525425
[TBL] [Abstract][Full Text] [Related]
9. Expression level of Wilms tumor 1 (WT1) protein has limited prognostic value in epithelial ovarian cancer: from the Danish "MALOVA" ovarian cancer study.
Høgdall EV; Christensen L; Kjaer SK; Blaakaer J; Christensen IJ; Gayther S; Jacobs IJ; Høgdall CK
Gynecol Oncol; 2007 Aug; 106(2):318-24. PubMed ID: 17540436
[TBL] [Abstract][Full Text] [Related]
10. [Significance of proliferating cell nuclear antigen (PCNA) index and microvessel density (MVD) in endometrial carcinoma].
Xiao L; Tang LD
Ai Zheng; 2005 Jan; 24(1):19-22. PubMed ID: 15642194
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of the Wilms' tumor gene WT1 in esophageal cancer.
Oji Y; Yano M; Nakano Y; Abeno S; Nakatsuka S; Ikeba A; Yasuda T; Fujiwara Y; Takiguchi S; Yamamoto H; Fujita S; Kanato K; Ito K; Jomgeow T; Kawakami M; Tsuboi A; Shirakata T; Nishida S; Hosen N; Oka Y; Aozasa K; Monden M; Sugiyama H
Anticancer Res; 2004; 24(5B):3103-8. PubMed ID: 15510596
[TBL] [Abstract][Full Text] [Related]
12. Expression of NLRP7 (PYPAF3, NALP7) protein in endometrial cancer tissues.
Ohno S; Kinoshita T; Ohno Y; Minamoto T; Suzuki N; Inoue M; Suda T
Anticancer Res; 2008; 28(4C):2493-7. PubMed ID: 18751440
[TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of progesterone receptor immunohistochemistry for lymph node metastases in endometrial carcinoma.
Iwai K; Fukuda K; Hachisuga T; Mori M; Uchiyama M; Iwasaka T; Sugimori H
Gynecol Oncol; 1999 Mar; 72(3):351-9. PubMed ID: 10053107
[TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical study of apoptosis-related Bcl-2 protein and its correlation with proliferation indices (Ki67, PCNA), tumor suppressor genes (p53, pRb), the oncogene c-erbB-2, sex steroid hormone receptors and other clinicopathological features, in normal, hyperplastic and neoplastic endometrium.
Mitselou A; Ioachim E; Kitsou E; Vougiouklakis T; Zagorianakou N; Makrydimas G; Stefanaki S; Agnantis NJ
In Vivo; 2003; 17(5):469-77. PubMed ID: 14598611
[TBL] [Abstract][Full Text] [Related]
15. Prognostic value of p53 and proliferating cell nuclear antigen expression in endometrial carcinoma.
Hamel NW; Sebo TJ; Wilson TO; Keeney GL; Roche PC; Suman VJ; Hu TC; Podratz KC
Gynecol Oncol; 1996 Aug; 62(2):192-8. PubMed ID: 8751548
[TBL] [Abstract][Full Text] [Related]
16. Co-expression of vascular endothelial growth factor and thymidine phosphorylase in endometrial cancer.
Fujiwaki R; Hata K; Iida K; Maede Y; Watanabe Y; Koike M; Miyazaki K
Acta Obstet Gynecol Scand; 1999 Sep; 78(8):728-34. PubMed ID: 10468067
[TBL] [Abstract][Full Text] [Related]
17. Expression of Wilms tumor gene (WT1) in epithelial ovarian cancer.
Hylander B; Repasky E; Shrikant P; Intengan M; Beck A; Driscoll D; Singhal P; Lele S; Odunsi K
Gynecol Oncol; 2006 Apr; 101(1):12-7. PubMed ID: 16263157
[TBL] [Abstract][Full Text] [Related]
18. Comparison of D&C and hysterectomy pathologic findings in endometrial cancer patients.
Wang X; Huang Z; Di W; Lin Q
Arch Gynecol Obstet; 2005 Jul; 272(2):136-41. PubMed ID: 15666177
[TBL] [Abstract][Full Text] [Related]
19. Proliferating cell nuclear antigen as a prognostic factor after total mesorectal excision of stage II-III rectal cancer.
Huh JW; Kim HR; Kim YJ
Ann Surg Oncol; 2009 Jun; 16(6):1494-500. PubMed ID: 19267156
[TBL] [Abstract][Full Text] [Related]
20. CaMKIV expression is associated with clinical stage and PCNA-labeling index in endometrial carcinoma.
Shang S; Takai N; Nishida M; Miyazaki T; Nasu K; Miyakawa I
Int J Mol Med; 2003 Feb; 11(2):181-6. PubMed ID: 12525874
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]